https://sputnikglobe.com/20210727/russian-health-ministry-greenlights-joint-trials-of-astrazeneca-sputnik-light-vaccines-1083467983.html
Russian Health Ministry Greenlights Joint Trials of AstraZeneca, Sputnik Light Vaccines
Russian Health Ministry Greenlights Joint Trials of AstraZeneca, Sputnik Light Vaccines
Sputnik International
MOSCOW (Sputnik) - The Russian Health Ministry approved joint trials of coronavirus vaccines AstraZeneca and Sputnik Light, according to its registry of... 27.07.2021, Sputnik International
2021-07-27T03:58+0000
2021-07-27T03:58+0000
2022-10-19T20:01+0000
world
newsfeed
russia
sputnik v vaccine
astrazeneca
vaccine
covid-19
coronavirus
sputnik
https://cdn1.img.sputnikglobe.com/img/07e5/07/06/1083320808_0:168:1935:1262_1920x0_80_0_0_21e94e9687a519b573f67e3b300f0e1b.jpg
"Simple, blinded, randomized, phase I/II study to determine the safety and immunogenicity of a combination of AZD1222 and rAd26-S, administered in a heterologous prime-boost scheme, to prevent the novel coronavirus infection COVID-19 in adults," the registry says.Sputnik Light is a one-component version of the Russian coronavirus vaccine, Sputnik V, developed by the Russian Direct Investment Fund (RDIF) and Gamaleya Institute. According to RDIF, Sputnik Light has shown 79.4% efficacy in preventing COVID-19, higher than some other two-dose vaccines.AstraZeneca is a UK-Swedish vaccine, developed by Oxford University and AstraZeneca. According to the data published in Lancet, the vaccine is 76.0% at preventing symptomatic COVID-19 following the first dose and 81.3% after the second dose.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, sputnik v vaccine, astrazeneca, vaccine, covid-19, coronavirus, sputnik
newsfeed, sputnik v vaccine, astrazeneca, vaccine, covid-19, coronavirus, sputnik
Russian Health Ministry Greenlights Joint Trials of AstraZeneca, Sputnik Light Vaccines
03:58 GMT 27.07.2021 (Updated: 20:01 GMT 19.10.2022) MOSCOW (Sputnik) - The Russian Health Ministry approved joint trials of coronavirus vaccines AstraZeneca and Sputnik Light, according to its registry of clinical trials approvals.
"Simple, blinded, randomized, phase I/II study to
determine the safety and immunogenicity of a combination of AZD1222 and rAd26-S, administered in a heterologous prime-boost scheme, to prevent the novel coronavirus infection COVID-19 in adults," the registry says.
The study will involve 150 patients and is scheduled to be completed on 2 March 2022.
Sputnik Light is a one-component version of the Russian coronavirus vaccine, Sputnik V, developed by the Russian Direct Investment Fund (RDIF) and Gamaleya Institute. According to RDIF, Sputnik Light has shown 79.4% efficacy in preventing COVID-19, higher than some other two-dose vaccines.
AstraZeneca is a UK-Swedish vaccine, developed by Oxford University and AstraZeneca. According to the data
published in Lancet, the vaccine is 76.0% at preventing symptomatic COVID-19 following the first dose and 81.3% after the second dose.
